Introducing Nili - An Innovative Digital Health Solution for Caregivers

During the 2023 ViVE Digital Health Event next week in Nashville, TN, we will announce the launch of Nili, an Innovative digital health solution designed to support the needs of seniors and patients living independently, while minimizing the burden of caregiving. Through an engaging tablet companion, Nili enables aging in place and activities of daily living management for older adults and patients, including individuals with dementia. Using the Nili Mobile App, multiple care partners can collaborate on managing and coordinating the care of their loved ones.

Nili was developed in collaboration with experts at Baylor College of Medicine and funded by a $2.9M award from the National Institutes on Aging (NIA). The platform is based on the latest research in dementia care, including a recent study published in Gerontology. The study found that coordinated care and support for individuals with dementia and their care partners can improve outcomes and reduce burden. A larger randomized clinical trial is underway (ClinicalTrials.gov Identifier: NCT04308512).

We would love the opportunity to meet in person and discuss collaboration opportunities during the 2023 ViVE Digital Health Event - as it relates to Nili or our wearable sensors and digital health technologies for clinical trials and research. We are exhibiting under the NIH Pavillion at Booth 749, Kiosk 2. 

About BioSensics: BioSensics is the leader in developing wearable sensors and digital health technologies for clinical trials, remote patient monitoring, and health assessments. Founded in 2007 by three scientists from Harvard, BioSensics has created new paradigms in using wearable sensors in healthcare and revolutionized the medical alert industry by creating technologies that are now used by thousands of older adults.

BioSensics is the only company that develops and provides end-to-end solutions and services for the collection of digital measures and biomarkers in clinical trials and research. All components of BioSensics solutions, including the wearable sensors, software, and algorithms are developed and validated by BioSensics. Our experienced research team provides comprehensive technical and scientific consulting, including study design and protocol development support, as well as statistical analysis. In addition, BioSensics clinical operations team provides comprehensive operational and logistics support for clinical trial projects.

The U.S. National Institute of Health (NIH) has awarded BioSensics over $50M to support its research and development programs. In 2022, NIH selected BioSensics to develop remote measurement technologies for use in clinical trials in individuals with rare diseases.